Integer Holdings Corporation
ITGR
NYSE·Healthcare·Medical - Devices·Mkt cap $4.3B
$126.50
▲ +0.80%
P/E
34.56
Mkt Cap
$4.3B
52-Wk Range
$62.00–$126.80
52-Week Range
$62.00 - $126.80
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 19.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Established relationships with multi-national OEM customers providing recurring revenue and high switching costs
- Vertically integrated manufacturing capabilities across multiple geographies enabling cost efficiency and supply chain resilience
- Specialized expertise in complex medical device manufacturing including miniaturization, biocompatibility, and regulatory compliance
- Diversified product portfolio across multiple therapeutic areas reducing customer concentration risk
- Decades of operational history (founded 1970) with deep industry knowledge and manufacturing excellence
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Steady revenue growth (8% YoY)
Value
Fairly valued vs Medical Devices peers
Momentum
Hot
+37.7% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying ITGR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 22, 2026
AUG 3, 2026
Reported EPS of $1.60 vs $1.38 consensus (+15.9% surprise). Revenue of $464.1M vs $451.1M expected (+2.9%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+15.9%
Revenue trend · last 8Q
—
+11%
+7%
+11%
+8%
+5%
+1%
-2%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$431.4M
$449.5M
$437.4M
$476.5M
$467.7M
$472.1M
$439.6M
$464.1M
Margins · last 8Q
Gross
24.3%
Operating
7.4%
Profit
5.1%
Wall Street consensus
7 analysts · 14% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
14%
Hold
86%
Sell
0%
Median Price Target
—
Latest: Benchmark · Aug 13, 2026
vs Industry
How ITGR stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related